Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2017

Dec 5, 2017

30291_dirs_2017-12-05_7562afce-57b7-47fa-be96-fc460742c569.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2017-11-29

Reporting Person: SHERWIN STEPHEN A (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-29 Common Stock G 250 Disposed 5734 Direct
2017-11-29 Common Stock G 200 Disposed 5534 Direct
2017-11-29 Common Stock G 400 Disposed 5134 Direct